Bulletin
Investor Alert

New York Markets After Hours

ADC Therapeutics S.A.

NYS: ADCT

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Jan 25, 2022, 4:10 p.m.

/zigman2/quotes/214411413/composite

$

16.11

Change

+0.66 +4.27%

Volume

Volume 236,229

Quotes are delayed by 20 min

/zigman2/quotes/214411413/composite

Previous close

$ 15.45

$ 16.11

Change

+0.66 +4.27%

Day low

Day high

$15.35

$16.69

Open

52 week low

52 week high

$13.34

$34.48

Open

Annual Financials for ADC Therapeutics S.A.

Fiscal year is January-December. All values USD millions. 2017201820192020 5-year trend
Sales/Revenue -1.8M1.14M2.34M-
Cost of Goods Sold (COGS) incl. D&A ----1.97M
COGS excluding D&A -----
Depreciation & Amortization Expense -341,000513,0001.65M1.97M
Depreciation -328,000488,0001.62M1.93M
Amortization of Intangibles -13,00025,00030,00047,000
Gross Income ----(1.97M)
2017201820192020 5-year trend
SG&A Expense -93.13M126.34M118.44M216.49M
Research & Development -85.33M117.74M104.62M139.71M
Other SG&A -7.81M-13.81M76.78M
Other Operating Expense -----
Unusual Expense --227,000-47.2M
EBIT after Unusual Expense --(125.94M)-(265.66M)
Non Operating Income/Expense -825,000213,000(255,000)(576,000)
Non-Operating Interest Income -1.03M2.86M2.25M832,000
Equity in Affiliates (Pretax) -----
Interest Expense ---156,0004.93M
Gross Interest Expense ---156,0004.93M
Interest Capitalized -----
Pretax Income -(89.81M)(122.87M)(115.9M)(270.33M)
Income Tax -48,000224,000582,000327,000
Income Tax - Current Domestic -48,000224,000582,000327,000
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates ----24.37M
Other After Tax Income (Expense) -----
Consolidated Net Income -(89.86M)(123.1M)(116.48M)(246.29M)
Minority Interest Expense -----
Net Income -(89.86M)(123.1M)(116.48M)(246.29M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(89.86M)(123.1M)(116.48M)(246.29M)
Preferred Dividends -----
Net Income Available to Common -(89.86M)(123.1M)(116.48M)(246.29M)
EPS (Basic) -(28,664.00)(33,019.00)(1.74)(3.77)
Basic Shares Outstanding -3,1353,72866.87M65.41M
EPS (Diluted) -(28,664.00)(33,019.00)(1.74)(3.77)
Diluted Shares Outstanding -3,1353,72866.87M65.41M
EBITDA -(91.33M)(125.2M)(116.1M)(216.49M)
Trending Tickers
  • /zigman2/quotes/200030751/composite CLSK-1.06%
  • /zigman2/quotes/228559245/composite ADGI-78.81%
  • /zigman2/quotes/216531076/composite ESSC-26.63%
  • /zigman2/quotes/211617595/composite BYND+9.29%
  • /zigman2/quotes/205021014/composite RUN-15.70%
X
Powered by StockTwits
Link to MarketWatch's Slice.